| Schizophrenia |
1 |
1 |
| Risk Evaluation and Mitigation Strategies |
0 |
1 |
| Food and Drug Administration (FDA) |
0 |
0.95 |
| Health Care Quality, Access, and Evaluation |
0 |
0.8 |
| Social Determinants of Health |
0 |
0.44 |
| Mental Illness |
0 |
0.15 |
| Neutrophils |
0 |
0.15 |
| Addiction |
0 |
0.1 |
| Substance Abuse |
0 |
0.1 |
| Abuse |
0 |
0.07 |
| Antipsychotics |
0 |
0.8 |
| Child |
0 |
0.07 |
| Dorsum |
0 |
0.07 |
| Immunization |
0 |
0.07 |
| Influenza |
0 |
0.07 |
| Maryland |
0 |
0.07 |
| Neutropenia |
0 |
0.07 |
| Schizoaffective Disorder |
0 |
1 |